ArticleOncogene2017

Transamidase site-targeted agents alter the conformation of the transglutaminase cancer stem cell survival protein to reduce GTP binding activity and cancer stem cell survival.

C Kerr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.